THERAPEUTIC ANTIBODIES AGAINST OSTEOPONTIN

THERAPEUTIC ANTIBODIES AGAINST OSTEOPONTIN

Therapeutic antibodies specific for osteopontin and methods of using them for treating osteopontin-associated disorders are provided. In particular, antibodies, or antigen-binding fragments thereof, that inhibit thrombin-cleavage of osteopontin or block the activity of thrombin cleavage fragments of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MYLES, Timothy, LEUNG, Lawrence L. K, MORSER, Michael J
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MYLES, Timothy
LEUNG, Lawrence L. K
MORSER, Michael J
description Therapeutic antibodies specific for osteopontin and methods of using them for treating osteopontin-associated disorders are provided. In particular, antibodies, or antigen-binding fragments thereof, that inhibit thrombin-cleavage of osteopontin or block the activity of thrombin cleavage fragments of osteopontin are provided. Additionally, antibody conjugates and pharmaceutical compositions or formulations comprising the antibodies or antibody conjugates as well as kits including the antibodies, conjugates, or formulations are also provided.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4010369A4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4010369A4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4010369A43</originalsourceid><addsrcrecordid>eNrjZNAK8XANcgxwDQ3xdFZw9AvxdPJ38XQNVnB0d_T0Cw5R8A8OcfUP8AdK-PEwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXABMDQwNjM0tHE2MilAAALaAklg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THERAPEUTIC ANTIBODIES AGAINST OSTEOPONTIN</title><source>esp@cenet</source><creator>MYLES, Timothy ; LEUNG, Lawrence L. K ; MORSER, Michael J</creator><creatorcontrib>MYLES, Timothy ; LEUNG, Lawrence L. K ; MORSER, Michael J</creatorcontrib><description>Therapeutic antibodies specific for osteopontin and methods of using them for treating osteopontin-associated disorders are provided. In particular, antibodies, or antigen-binding fragments thereof, that inhibit thrombin-cleavage of osteopontin or block the activity of thrombin cleavage fragments of osteopontin are provided. Additionally, antibody conjugates and pharmaceutical compositions or formulations comprising the antibodies or antibody conjugates as well as kits including the antibodies, conjugates, or formulations are also provided.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231122&amp;DB=EPODOC&amp;CC=EP&amp;NR=4010369A4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231122&amp;DB=EPODOC&amp;CC=EP&amp;NR=4010369A4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MYLES, Timothy</creatorcontrib><creatorcontrib>LEUNG, Lawrence L. K</creatorcontrib><creatorcontrib>MORSER, Michael J</creatorcontrib><title>THERAPEUTIC ANTIBODIES AGAINST OSTEOPONTIN</title><description>Therapeutic antibodies specific for osteopontin and methods of using them for treating osteopontin-associated disorders are provided. In particular, antibodies, or antigen-binding fragments thereof, that inhibit thrombin-cleavage of osteopontin or block the activity of thrombin cleavage fragments of osteopontin are provided. Additionally, antibody conjugates and pharmaceutical compositions or formulations comprising the antibodies or antibody conjugates as well as kits including the antibodies, conjugates, or formulations are also provided.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAK8XANcgxwDQ3xdFZw9AvxdPJ38XQNVnB0d_T0Cw5R8A8OcfUP8AdK-PEwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXABMDQwNjM0tHE2MilAAALaAklg</recordid><startdate>20231122</startdate><enddate>20231122</enddate><creator>MYLES, Timothy</creator><creator>LEUNG, Lawrence L. K</creator><creator>MORSER, Michael J</creator><scope>EVB</scope></search><sort><creationdate>20231122</creationdate><title>THERAPEUTIC ANTIBODIES AGAINST OSTEOPONTIN</title><author>MYLES, Timothy ; LEUNG, Lawrence L. K ; MORSER, Michael J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4010369A43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>MYLES, Timothy</creatorcontrib><creatorcontrib>LEUNG, Lawrence L. K</creatorcontrib><creatorcontrib>MORSER, Michael J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MYLES, Timothy</au><au>LEUNG, Lawrence L. K</au><au>MORSER, Michael J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THERAPEUTIC ANTIBODIES AGAINST OSTEOPONTIN</title><date>2023-11-22</date><risdate>2023</risdate><abstract>Therapeutic antibodies specific for osteopontin and methods of using them for treating osteopontin-associated disorders are provided. In particular, antibodies, or antigen-binding fragments thereof, that inhibit thrombin-cleavage of osteopontin or block the activity of thrombin cleavage fragments of osteopontin are provided. Additionally, antibody conjugates and pharmaceutical compositions or formulations comprising the antibodies or antibody conjugates as well as kits including the antibodies, conjugates, or formulations are also provided.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4010369A4
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title THERAPEUTIC ANTIBODIES AGAINST OSTEOPONTIN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T23%3A03%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MYLES,%20Timothy&rft.date=2023-11-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4010369A4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true